Dan and Mike share Medicarians takeaways on technology, AI, distribution, and compensation before examining the 2026 CMS final rule. They discuss both the issues addressed and areas they say remain unresolved, particularly agent and FMO commissions and marketing requirements. The conversation also considers carrier planning and how state Medicare Supplement access rules can influence the market.

In this episode

  • Medicarians recap
  • 2026 CMS final rule
  • FMO compensation
  • Technology and AI
  • Medigap state rules

Show notes

Updates, Medicarians Recap & AI in Healthcare | Episode 83Agent Boost is back in the studio after an intense travel schedule! In this episode, Dan and Mike discuss their recent trip to the Medicarians 2025. Key topics include the latest CMS call letter and its implications, exciting updates in funding for Medicare Advantage plans, and the role of artificial intelligence in healthcare. They also delve into the industry's focus on ancillary products, and share their thoughts on the effectiveness of ship counselors based on a recent JAMA survey. Don't miss insights on navigating the complex world of Medicare!💻 Website: Contracted: our Facebook Group: Our Weekly Newsletter